drugset / Trial / NCT02928354

A Study to Assess the Effect of Particle Size of AZD7594 on Pharmacokinetics (PK) After a Single Inhaled Dose When Administered Using the Dry Powder Inhaler in Healthy Volunteers

NCT02928354

Phase 1 Completed 12 enrolled AstraZeneca
RandomizedCrossoverOpen-labelTreatment

Summary

This study is an open label, randomized, three-way crossover study to assess the effect of particle size on the PK and safety of single inhaled doses of AZD7594 in healthy subjects (males aged 18 to 55 years \[inclusive\]). The study will be performed at a single study center.

Timeline

Start
2016-11-25
Primary completion
2017-03-21
Completion
2017-03-21

Drugs

EvaluationDrugModalityDoseRoute
Subject VELSECORAT Other / unclassified 440 ug Inhaled

Indications

No indication recorded.